Pulmonary Hypertension News and Research

RSS
Pulmonary arterial hypertension (PAH) is a condition involving high blood pressure and structural changes in the walls of the pulmonary arteries, which are the blood vessels that connect the right side of the heart to the lungs. Affecting people of all ages and ethnic backgrounds - but most commonly found in young women of child-bearing years - the disease has historically been chronic and incurable, with a poor survival rate. PAH is often not diagnosed in a timely manner because its early symptoms can be confused with those of many other pulmonary and respiratory conditions. Symptoms include shortness of breath, extreme fatigue, dizziness, fainting, swollen ankles and legs and chest pain (especially during physical activity). With proper diagnosis, there are currently several therapies to alleviate symptoms and improve quality of life for PAH patients. The key is to find a PAH specialist and pursue immediate treatment.
Owlstone Medical announces strategic collaboration with Actelion to improve lives of people with pulmonary hypertension

Owlstone Medical announces strategic collaboration with Actelion to improve lives of people with pulmonary hypertension

More care is needed for patients after kidney transplantations, reports research

More care is needed for patients after kidney transplantations, reports research

UCI discovery may lead to mitigation of side effects caused by erectile dysfunction drugs

UCI discovery may lead to mitigation of side effects caused by erectile dysfunction drugs

Echocardiography may aid in patient selection for TMVR

Echocardiography may aid in patient selection for TMVR

Up-to-date guidance for clinicians to treat HIV-related cardiovascular disease

Up-to-date guidance for clinicians to treat HIV-related cardiovascular disease

Several health experts worldwide gather at EUDONORGAN event

Several health experts worldwide gather at EUDONORGAN event

Specialized lung cells appear in the developing fetus much earlier than previously thought

Specialized lung cells appear in the developing fetus much earlier than previously thought

Fetal signaling pathways may offer future opportunities to treat lung damage

Fetal signaling pathways may offer future opportunities to treat lung damage

New clinical practice guideline on home oxygen therapy for children

New clinical practice guideline on home oxygen therapy for children

Protein which plays role in sensing cell damage serves as new target to treat pulmonary hypertension

Protein which plays role in sensing cell damage serves as new target to treat pulmonary hypertension

New genetic pathways associated with severe lung disease identified in extremely premature infants

New genetic pathways associated with severe lung disease identified in extremely premature infants

Two related enzymes have opposing roles in heart failure

Two related enzymes have opposing roles in heart failure

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Study finds new enzyme that lays foundations for allergic immune response

Study finds new enzyme that lays foundations for allergic immune response

CVIA publishes special issue on adult congenital heart disease

CVIA publishes special issue on adult congenital heart disease

NUS researchers find novel pathway to regulate blood pressure

NUS researchers find novel pathway to regulate blood pressure

Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Scientists develop integrated system for early diagnosis of diseases using wearable monitors

Scientists develop integrated system for early diagnosis of diseases using wearable monitors

PFKFB3 enzyme appears to play a key role in pulmonary hypertension

PFKFB3 enzyme appears to play a key role in pulmonary hypertension

Scientists discover new target in the treatment of pulmonary hypertension

Scientists discover new target in the treatment of pulmonary hypertension